Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2064-2073

  Djerbi, Mounira ^a   Abdul Majid, Khairul Bariah ^b   Abedi Valugerdi, Manuchehr ^a   Olsson, Tomas ^b   Harris, Robert A ^b   Grandien, Alf ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; GENE PRODUCT; GLYCOPROTEIN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMISSION; RETROVIRUS; T LYMPHOCYTE; TH1 CELL;

EID: 0037442212     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2064     Document Type: Article

References (73)

1. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349.
2. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H. C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
3. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579.
4. - T lymphocytes. J. Immunol. 127:1420.
5. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
6. Svensson, L., K. B. Abdul-Majid, J. Bauer, H. Lassmann, R. A. Harris, and R. Holmdahl. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32:1939.
7. Abdul-Majid, K. B., A. Stefferl, C. Bourquin, H. Lassmann, C. Linington, T. Olsson, S. Kleinau, and R. A. Harris. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55:70.
8. q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J. Neuroimmunol. 111:23.
9. Chen, Y., W. W. Hancock, R. Marks, P. Gonnella, and H. L. Weiner. 1998. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol. 82:149.
10. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
11. Cannella, B., Y. L. Gao, C. Brosnan, and C. S. Raine. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735.
12. Wyss-Coray, T., P. Borrow, M. J. Brooker, and L. Mucke. 1997. Astroglial over-production of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77:45.
13. Chu, C. Q., S. Wittmer, and D. K. Dalton. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 123.
14. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193:427.
15. Furtado, G. C., D. Olivares-Villagomez, M. A. Curotto De Lafaille, A. K. Wensky, J. A. Latkowski, and J. J. Lafaille. 2001. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol. Rev. 182:122.
16. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98:6301.
17. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
18. + T cells. J. Neuroimmunol. 97:25.
19. Zhang, B., T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1677.
20. Pender, M. P., P. A. McCombe, G. Yoong, and K. B. Nguyen. 1992. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmun. 5:401.
21. + encephalitogenic T cells. Eur. J. Immunol. 24:2609.
22. Tabi, Z., P. A. McCombe, and M. P. Pender. 1995. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 7:967.
23. Russell, J. H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90:4409.
24. Russell, J. H., and R. Wang. 1993. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23:2379.
25. Scott, D. E., W. J. Kisch, and A. D. Steinberg. 1993. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupusprone mice. J. Immunol. 150:664.
26. Pender, M. P. 1998. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 351:978.
27. Ciusani, E., S. Frigerio, M. Gelati, E. Corsini, A. Dufour, A. Nespolo, L. La Mantia, C. Milanese, G. Massa, and A. Salmaggi. 1998. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 82:5.
28. Comi, C., M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani. 2000. Defective T cell fas function in patients with multiple sclerosis. Neurology 55:921.
29. Zipp, F., M. Weller, P. A. Calabresi, J. A. Frank, C. N. Bash, J. Dichgans, H. F. McFarland, and R. Martin, 1998. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann. Neurol. 43:116.
30. Bonetti, B., J. Pohl, Y. L. Gao, and C. S. Raine. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:5733.
31. Kohji, T., and Y. Matsumoto. 2000. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106:165.
32. Ouallet, J., N. Baumann, Y. Marie, and H. Villarroya. 1999. Fas system up-regulation in experimental autoimmune encephalomyehtis. J. Neurol. Sci. 170:96.
33. Suvannavejh, G. C., M. C. Dal Canto, L. A. Matis. and S. D. Miller. 2000. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:223.
34. White, C. A., P. A. McCombe, and M. P. Pender. 1998. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82:47.
35. White, C. A., K. B. Nguyen, and M. P. Pender. 2000. B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expression. J. Autoimmun. 14:195.
36. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Bums, J.-L. Bodmer, M. Schröter. et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517.
37. Thome, M., and J. Tschopp. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1:50.
38. Djerbi, M., T. Darreh-Shori, B. Zhivotovsky, and A. Grandien. 2001. Characterization of the human FLICE-inhibitory protein locus and comparison of the antiapoptotic activity of four different FLIP isoforms. Scand. J. Immunol. 54:180.
39. Scaffidi, C., I. Schmitz. P. H. Krammer, and M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541.
40. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487.
41. Krueger, A., I. Schmitz, S. Baumann, P. H. Krammer, and S. Kirchhofr. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276:20633.
42. Van Parijs, L., Y. Refaeli, A. K. Abbas, and D. Baltimore. 1999. Autoimmunity as a consequence of retrovirus-mediated expression of C- FLIP in lymphocytes. Immunity 11:763.
43. Sharief, M. K. 2000. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis. J. Neuroimmunot. 111:203.
44. Semra, Y. K., O. A. Seidi, and M. K. Sharief. 2001. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 113:268.
45. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
46. Collins, L. S., and K. Dorshkind. 1987. A stromal cell line from myeloid longterm bone marrow cultures can support myelopoiesis and B lymphopoiesis. J. Immunol. 138:1082.
47. Juedes, A. E., P. Hjelmstrom, C. M. Bergman, A. L. Neild, and N. H. Ruddle. 2000. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 164:419.
48. Lagasse, E., and I. L. Weissman. 1996. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197:139.
49. Sabelko-Downes, K. A., A. H. Cross, and J. H. Russell. 1999. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1195.
50. Dittel, B. N., R. M. Merchant, and C. A. Janeway, Jr. 1999. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162:6392.
51. Wildbaum, G., J. Westermann, G. Maor, and N. Karin. 2000. A targeted DNA vaccine encoding fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis. J. Clin. Invest. 106:671.
52. Bachmann, R., H. P. Eugster, K. Frei, A. Fontana, and H. Lassmann. 1999. Impairment of TNF-receptor-I signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am. J. Pathol. 154:1417.
53. Malipiero, U., K. Frei, K. S. Spanaus, C. Agresti, H. Lassmann, M. Hahne, J. Tschopp, H. P. Eugster, and A. Fontana. 1997. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27:3151.
54. Schmidt, J., R. Gold, L. Schonrock, U. K Zettl, H. P. Hartung, and K. V. Toyka. 2000. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123:1431.
55. Zettl, U. K., E. Mix, J. Zielasek, M. Stangel, H. P. Hartung, and R. Gold. 1997. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell. Immunol. 178:1.
56. Holler, N., R. Zaru, O. Micheau, M. Thome, A. Attinger, S. Valitutti, J. L. Bodmer, P. Schneider, B. Seed, and J. Tschopp. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immun. 1:489.
57. Adams, J. M., and S. Cory. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:61.
58. Issazadeh, S., K. Abdallah, T. Chitnis, A. Chandraker, A. D. Wells, L. A. Turka, M. H. Sayegh, and S. J. Khoury. 2000. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:1109.
59. Sharief, M. K., M. Douglas, M. Noori, and Y. K. Semra. 2002. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 125:155.
60. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J. Neurol. Sci. 139:1.
61. Cross, A. H., B. Cannella, C. F. Brosnan, and C. S. Raine. 1990. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:162.
62. Steinman, L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA 93:2253.
63. Bauer, J., M. Bradl, W. F. Hickley, S. Forss-Petter, H. Breitschopf, C. Linington, H. Wekerle, and H. Lassmann. 1998. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 153:715.
64. White, C. A., P. A. McCombe, and M. P. Pender. 1998. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int. Immunol. 10:935.
65. Imrich, H., and K. Harzer. 2001. On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE). J. Neural Transm. 108: 379.
66. McColl, S. R., M. A. Staykova, A. Wozniak, S. Fordham, J. Bruce, and D. O. Willenborg. 1998. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161: 6421.
67. Reiseter, B. S., G. T. Miller. M. P. Happ, and M. T. Kasaian. 1998. Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid. J. Neuroimmunol. 91:156.
68. Nygardas, P. T., J. A. Maatta, and A. E. Hinkkanen. 2000. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse. Eur. J. Immunol. 30:1911.
69. Schlapbach, R., K. S. Spanaus, U. Malipiero, S. Lens, A. Tasinato, J. Tschopp, and A. Fontana. 2000. TGF-β induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur. J. Immunol. 30: 3680.
70. Begolka, W. S., and S. D. Miller. 1998. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res. Immunol. 149:771.
71. Liblau, R., L. Steinman, and S. Brocke. 1997. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol. 9:799.
72. Di Rosa, F., A. Francesconi, A. Di Virgilio, L. Finocchi, I. Santilio, and V. Barnaba. 1998. Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis. Eur. J. Immunol. 28:3893.
73. Okuda, Y., S. Sakoda, C. C. Bernard, and T. Yanagihara. 1998. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an up-regulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J. Interferon Cytokine Res. 18:415.